http://rdf.ncbi.nlm.nih.gov/pubchem/measuregroup/AID1802492_PMID

Outgoing Links

Predicate Object
has specified output http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID329969713_AID1802492_PMID_VALUE5
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID329969712_AID1802492_PMID_VALUE4
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID329969715_AID1802492_PMID_VALUE7
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID329969714_AID1802492_PMID_VALUE6
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID329969711_AID1802492_PMID_VALUE3
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID329969716_AID1802492_PMID_VALUE8
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID329969709_AID1802492_PMID_VALUE1
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID329969710_AID1802492_PMID_VALUE2
has participant http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP31749
source http://rdf.ncbi.nlm.nih.gov/pubchem/source/BindingDB
title Akt1 TR-FRET assay from US Patent US9260435: \"Substituted imidazopyrazines as Akt kinase inhibitors\"
type http://www.bioassayontology.org/bao#BAO_0000040

Incoming Links

Predicate Subject
participates in http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID329969710
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID329969712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID329969716
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID329969713
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID329969714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID329969711
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID329969715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID329969709
has measure group http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1802492

Total number of triples: 21.